219 related articles for article (PubMed ID: 33823624)
1. Establishment of validated stability indicating purity method based on the stress degradation behavior of gonadotropin-releasing hormone antagonist (ganirelix) in an injectable formulation using HPLC and LC-MS-QTOF.
Ummiti K; Shanmukha Kumar JV
Eur J Mass Spectrom (Chichester); 2021 Apr; 27(2-4):126-140. PubMed ID: 33823624
[TBL] [Abstract][Full Text] [Related]
2. LC/Q-TOF-MS-based structural characterization of enasidenib degradation products and establishment of a stability-indicating assay method: Insights into chemical stability.
Chakkar A; Chaturvedi S; Rajput N; Sengupta P; Sharma N
Rapid Commun Mass Spectrom; 2024 Mar; 38(5):e9696. PubMed ID: 38355880
[TBL] [Abstract][Full Text] [Related]
3. Study on forced degradation behaviour of dofetilide by LC-PDA and Q-TOF/MS/MS: Mechanistic explanations of hydrolytic, oxidative and photocatalytic rearrangement of degradation products.
Thalluri B; Dhiman V; Tiwari S; Baira SM; Kumar Talluri MVN
J Pharm Biomed Anal; 2020 Feb; 179():112985. PubMed ID: 31780282
[TBL] [Abstract][Full Text] [Related]
4. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
[TBL] [Abstract][Full Text] [Related]
5. Use of the hyphenated LC-MS/MS technique and NMR/IR spectroscopy for the identification of exemestane stress degradation products during the drug development.
Stolarczyk EU; Rosa A; Kubiszewski M; Zagrodzka J; Cybulski M; Kaczmarek Ł
Eur J Pharm Sci; 2017 Nov; 109():389-401. PubMed ID: 28865686
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of alkaline and oxidative stressed degradation products of lurasidone using LC/ESI/QTOF/MS/MS.
Kumar Talluri MVN; Dharavath S; Kalariya PD; Prasanth B; Srinivas R
J Pharm Biomed Anal; 2015 Feb; 105():1-9. PubMed ID: 25527975
[TBL] [Abstract][Full Text] [Related]
8. Identification of degradation products of brivaracetam using liquid chromatography quadrupole time-of-flight tandem mass spectrometry: Degradation pathway elucidation.
Xu K; Ning M; Li W; Dong H; Lu Y; Hang T; Song M
Rapid Commun Mass Spectrom; 2024 Jan; 38(2):e9651. PubMed ID: 38124167
[TBL] [Abstract][Full Text] [Related]
9. LC-MS-Compatible Chromatographic Method for Quantification of Potential Organic Impurities of Elagolix Sodium in Tablet Dosage Form with Identification of Major Degradation Products.
Desai P; Prajapati R; Chokshi A
J AOAC Int; 2023 May; 106(3):568-579. PubMed ID: 36721330
[TBL] [Abstract][Full Text] [Related]
10. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
11. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.
Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S
J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964
[TBL] [Abstract][Full Text] [Related]
12. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
[TBL] [Abstract][Full Text] [Related]
13. Method validation and characterization of stress degradation products of azelastine hydrochloride using LC-UV/PDA and LC-Q/TOF-MS studies.
Shekhar S; Bali A
Rapid Commun Mass Spectrom; 2024 Apr; 38(7):e9712. PubMed ID: 38351666
[TBL] [Abstract][Full Text] [Related]
14. Analytical method development, identification, and characterization of stress degradation products of idelalisib by ultrahigh-performance liquid chromatography with photodiode array and ultrahigh-performance liquid chromatography with electrospray ionization quadrupole time-of-flight mass spectrometry studies.
Mahesh M; Bali A; Gupta T
Rapid Commun Mass Spectrom; 2024 Jun; 38(11):e9745. PubMed ID: 38591150
[TBL] [Abstract][Full Text] [Related]
15. Forced degradation study of baricitinib and structural characterization of its degradation impurities by high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy.
Chaganti S; Dhiman V; Madhyanapu Golla V; K R R; Khemchandani R; Samanthula G
Rapid Commun Mass Spectrom; 2023 Sep; 37(18):e9605. PubMed ID: 37580847
[TBL] [Abstract][Full Text] [Related]
16. Identification of forced degradation products of tamsulosin using liquid chromatography/electrospray ionization tandem mass spectrometry.
Namdev D; Borkar RM; Raju B; Kalariya PD; Rahangdale VT; Gananadhamu S; Srinivas R
J Pharm Biomed Anal; 2014 Jan; 88():245-55. PubMed ID: 24083958
[TBL] [Abstract][Full Text] [Related]
17. Selective separation and characterisation of stress degradation products and process impurities of prucalopride succinate by LC-QTOF-MS/MS.
Mahamuni BS; Jajula A; Awasthi A; Kalariya PD; Talluri MV
J Pharm Biomed Anal; 2016 Jun; 125():219-28. PubMed ID: 27037978
[TBL] [Abstract][Full Text] [Related]
18. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
[TBL] [Abstract][Full Text] [Related]
19. LC-PDA-QTof-MS characterization of the stress degradation products of Zanubrutinib: A novel BTK inhibitor.
Bhandi MM; Swain D; Ragampeta S; Mudiam MKR
J Pharm Biomed Anal; 2023 Nov; 236():115714. PubMed ID: 37713985
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of forced degradation products of vortioxetine by LC/MS/MS and NMR.
Ragi NC; Velma GR; Pallerla PK; Siddiqua S; Alugonda V; Rachamalla HKR; Pabbaraja S; Sripadi P
J Pharm Biomed Anal; 2020 Sep; 188():113442. PubMed ID: 32622114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
